Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 321,083 | 287,268 | 212,802 | 137,250 | 103,320 |
| Cost of Goods | 24,448 | 18,122 | 9,065 | 4,513 | 3,445 |
| Gross Profit | 296,635 | 269,146 | 203,737 | 132,737 | 99,875 |
| Operating Expenses | 356,692 | 383,243 | 251,004 | 212,561 | 167,317 |
| Operating Income | -59,609 | -113,975 | -47,202 | -79,311 | -66,997 |
| Interest Expense | 8,297 | 7,451 | 3,264 | 3,297 | 3,498 |
| Other Income | 9,331 | 7,236 | 8,185 | 9,370 | 11,079 |
| Pre-tax Income | -58,575 | -114,190 | -42,281 | -73,238 | -59,416 |
| Net Income Continuous | -58,575 | -114,190 | -42,281 | -73,238 | -59,416 |
| Net Income | $-58,575 | $-114,190 | $-42,281 | $-73,238 | $-59,416 |
| EPS Basic Total Ops | -2.55 | -5.08 | -1.90 | -3.32 | -2.50 |
| EPS Basic Continuous Ops | -2.55 | -5.08 | -1.90 | -3.32 | -2.51 |
| EPS Diluted Total Ops | -2.55 | -5.08 | -1.90 | -3.32 | -2.50 |
| EPS Diluted Continuous Ops | -2.55 | -5.08 | -1.90 | -3.32 | -2.51 |
| EPS Diluted Before Non-Recurring Items | -2.57 | -5.08 | -1.90 | -3.32 | -2.71 |
| EBITDA(a) | $-57,201 | $-111,737 | $-46,399 | $-78,440 | $-66,094 |